SUPPRESSION OF CLONIDINE-INDUCED RELEASE OF GROWTH-HORMONE BY THYROTROPIN RELEASING HORMONE IN HUMANS

被引：11
作者：
ZANOBONI, A
ZANOBONIMUCIACCIA, W
ZANUSSI, C
BARALDI, R
机构：
[1] Istituto di Clinica Medica, Dell’Università di Milano, Milano, 20122
来源：
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION | 1979年 / 2卷 / 04期
关键词：
alpha-adrenoreceptors; Clonidine; GH; hypothalamus; pituitary; TRH;
D O I：
10.1007/BF03349332
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
A single oral dose of clonidine (0.15 mg), a selective alpha-adrenergic stimulating agent, was able to increase plasma growth hormone (GH) levels (above 5 ng/ml) in 6 out of 7 normal men tested. This GH increase was independent of the hypotensive effect of the drug and was observed without any modification of plasma prolactin, thyroid stimulating hormone, gonadotropins and glycemia. When oral clonidine administration was associated to a slow thyrotropin releasing hormone (TRH) infusion (1 mg dissolved in 400 ml of 0.9% saline solution, at a constant rate during 150 min) the plasma GH response was significantly inhibited when compared with that observed after clonidine alone. These results suggest that in normal subjects TRH is capable of blocking the effect of an alpha-adrenergic stimulus which is conceivably acting at the level of central nervous system. © 1978, Italian Society of Endocrinology (SIE). All rights reserved.
引用
收藏
页码：347 / 351
页数：5
相关论文
共 38 条
  • [1] Martin J.B., Neural regulation of growth hormone secretion, N. Engl. J. Med., 288, (1973)
  • [2] Martin J.B., Brain regulation of growth hormone secretion, Frontiers in neuroendocrinology, 4, (1976)
  • [3] Lebovitz H.E., Skyler J.S., Boyd A.E., L-dopa and growth hormone secretion in man, Adv. Neurol., 5, (1974)
  • [4] Kleinberg D.L., Noel G.L., Frantz A.G., Chlorpromazine stimulation and L-dopa suppression of plasma prolactin in man, J. Clin. Endocrinol. Metab., 33, (1971)
  • [5] Malarkey W.B., Jacobs L.S., Daughaday W.H., Levodopa suppression of prolactin in nonpuerperal galactorrhea, N. Engl. J. Med., 285, (1971)
  • [6] Brown W.A., von Woert M.H., Ambrain L.M., Effect of apomorphine on growth hormone release in humans, J. Clin. Endocrinol. Metab., 37, (1973)
  • [7] Lai S., De la Vega C.E., Sourkes T.L., Friesen H.G., Effect of apomorphine on growth hormone, prolactin, luteinizing hormone and follicle-stimulating hormone levels in human serum, J. Clin. Endocrinol. Metab., 37, (1973)
  • [8] Camanni F., Massara F., Belforte L., Molinatti G.M., Changes in plasma growth hormone levels in normal and cromegalic subjects following administration of 2-bromo-alpha-ergocryptine, J. Clin. Endocrinol. Metab., 40, (1975)
  • [9] Thorner M.O., Wass J.A.H., Jones A., Bloom S.R., Mac R.M.L., Effect of piribedil infusions on circulating growth hormone, insulin, glucagon, cortisol and blood sugar in man, (1976)
  • [10] Imura H., Kato Y., Ikeda M., Morimoto M., Yawata M., Effects of adrenergic-blocking or -stimulating agents on plasma growth hormone, immunoreactive insulin and blood free fatty acid levels in man, J. Clin. Invest., 50, (1971)
1234